Frequently asked questions
Information on the exchange of Genussscheine for participation certificates (Partizipationsscheine) and related matters
Roche bearer shares, participation certificates, and ADRs
| Security | Ticker symbol | Listing/trading | ISIN/CUSIP |
|---|---|---|---|
Roche's bearer shares and participation certificates are quoted on the electronic SIX Swiss Exchange. Roche securities are also traded over-the-counter (OTC) on various other exchanges.
The Roche Group (of which Genentech is a wholly-owned member) is traded in the United States as a U.S.-dollar denominated American Depositary Receipt on the OTCQX International Premier market under the stock symbol: RHHBY.
Please refer to the following website for more information on how to invest in Roche and Genentech in the US.
702,562,700 bearer participation certificates with a nominal value of CHF 0.001 each
106,691,000 bearer shares with a nominal value of CHF 0.001 each
Roche Holding Ltd places no restrictions on ownership of its shares and participation certificates. Each participation certificate confers the same rights as one share to participate in available earnings and any liquidation proceeds remaining after repayment of the nominal value of the shares and the participation certificate capital.
Please refer to the following web sites:
As of 1 January 2000, Roche’s share capital recorded in the commercial register amounted to CHF 160,000,000 and was divided into 1,600,000 bearer shares with a nominal value of CHF 100 each and Roche had issued 702,562,700 non-voting equity securities.
As of 3 March 2001, Roche’s share capital recorded in the commercial register amounted to CHF 160,000,000 and was divided into 160,000,000 bearer shares with a nominal value of CHF 1 each and Roche had issued 702,562,700 non-voting equity securities.
On 26 November 2021, an extraordinary general meeting approved a share capital reduction by CHF 53,309,000 from CHF 160,000,000 to CHF 106,691,000 by reducing the number of bearer shares to 106,691,000 and cancelling 53,309,000 bearer shares. This became effective with the entry of the share capital reduction in the commercial register of the Canton of Basel-Stadt on 3 February 2022 and the publication of the share capital reduction in the SOGC on 8 February 2022.
On 10 March 2026, the annual general meeting approved the exchange of non-voting equity securities for participation certificates and a reduction in the nominal value of the bearer shares from CHF 1 to CHF 0.001 per share. The reduction amount of CHF 0.999 per bearer share was repaid to shareholders in the form of a cash payment. As of 11 March 2026, Roche’s share capital amounted to CHF 106,691 and was divided into 106,691,000 fully paid-up bearer shares with a nominal value of CHF 0.001 each. Roche’s participation capital issued amounted to CHF 702,562.70 and was divided into 702,562,700 fully paid-up bearer participation certificates with a nominal value of CHF 0.001 each.
Eight Roche ADRs represent one underlying participation certificate (ROP).
Because its shares are bearer shares, Roche cannot and does not keep a register of its shareholders. Information for holders of bearer shares, including invitations to the Annual General Meeting, is disseminated by publication in the Schweizerisches Handelsamtsblatt (Swiss Official Gazette of Commerce), various Swiss daily and financial newspapers and the Roche website.
Dividends
An overview of the dividend payments of the last years can be found on the Share and Bond informationwebsite
An overview of the dividend payments of the last years can be found on the Share and Bond informationwebsite
The payment date is the date on which the dividend is paid and is at least three trading days after the ex-dividend date. Dividends are therefore paid no earlier than the fifth day of trading on SIX Swiss Exchange after the Annual General Meeting.
Please find more information on the annual general meeting page.
The ex-dividend date is the first trading day on which bearer shares and participation certificates do not entitle buyers to a dividend. It is generally the first day of trading after the day on which SIX Swiss Exchange receives confirmation of the dividend by 11 a.m. – i.e. the second day of trading after the Annual General Meeting.
When shares and/or participation certificates are purchased "ex-dividend", the seller of the shares and/or participation certificates, not the purchaser, is entitled to receive the next dividend payment.
Due to harmonisation of corporate action processes, many European countries have introduced a record date for dividend payments in the form of cash or shares. SIX SIS AG has also decided to introduce a record date for Switzerland as of 23 November 2009.
The record date serves for internal settlement procedures of the SIS SIX AG and the banks and is the date on which the technical entitlement to dividend payments is established after close of trading. Since 6 October 2014, the record date falls on the first trading day following the ex-dividend date.
Specifically, the introduction of the record date means that SIX SIS AG will no longer determine the entitled positions on the ex date, (i.e., first trading day on which the shares are traded ex dividend) but at the record date.
No.
The dividend payout increased from year to year.
Yearly dividend
:quality(90)/)
An overview of the dividend history can be found on the Share and Bond informationwebsite.
Annual General Meeting
Please find this information on the annual general meeting page.
Holders of bearer shares will be invited to attend by notices published in the Swiss Official Gazette of Commerce (Schweizerisches Handelsamtsblatt), various Swiss daily and financial newspapers as well as on the Roche website. Further information
Information about the last Annual General Meeting.
Yes, shareholders can be represented by proxy at the AGM. A proxy being shareholders and non-shareholders, and the independent proxy.
Further information can be found in the Articles of Incorporation(Articles of Incorporation § 12), which contain the principal information - required by law - on Roche's business purpose, structures and statutory bodies.
Shareholders wishing to exercise their voting rights at the annual General Meeting of Roche Holding Ltd and participate in the voting and election processes can generally order their documents for the exercise of voting rights from approx. February of the respective year. Additional information on the requirements and process can be found here.
Annual Report, Corporate Governance and Corporate Sustainability
Please visit our Document Centre
Roche is committed to serving all its stakeholders. As a basis for the successful implementation of this commitment our Corporate Governance principles prescribe a management culture conforming to recognised standards of good corporate governance and a policy of transparent communication. More information can be found on the Governance website.
Our Sustainability Strategy builds on our purpose and establishes clear priorities to create long-term societal and financial value. We are taking action to integrate sustainability into everything we do. More information can be found on the Sustainability website.
As of 2005, reporting on sustainability related topics has been incorporated into the Annual Report. Information on topics relating to sustainability can be found in the Sustainability Report section of the Annual Report.
Contacts
Please contact the Investor Relations Team via email or via phone.
F. Hoffmann-La Roche Ltd
Investor Relations
CH-4070 Basel
Switzerland
Telephone +41-61-688 8880
Fax +41-61-691 0014